In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae-Reference-Cited by-同舟云学术

In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae

Published:1999-08 Issue:4 Volume:12 Page:319-323
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Dhople Arvind M.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference23 articles.

1. Two and a half years’ experimental work on the sulfone groups of drugs;Cochrane;Lepr. Rev.,1949

2. World Health Organization. Study group on chemotherapy of leprosy for control programs. WHO Tech Rep Serv 1982; 675.

3. Drug resistance in leprosy;Ji;Lepr. Rev.,1985

4. New analogs of trimethoprim;Then;Rev. Infect. Dis.,1982

5. Trimethoprim, a sulfonamide potentiator;Bushby;Br. J. Pharmacol.,1968

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and structural studies of oxathiepine, benzo[ b ][1, 4]thiazine and quinolin-4-ol derivative based on 3-bromo-4-hydroxy-7-methoxyquinolin-2-one;Synthetic Communications;2024-09-03

2. Increscent journey of anti-leprosy drug development;CURR SCI INDIA;2023

3. Identification of P218 as a potent inhibitor of Mycobacterium ulcerans DHFR;RSC Medicinal Chemistry;2021

4. pH-responsive chitosan based hydrogels affect the release of dapsone: Design, set-up, and physicochemical characterization;International Journal of Biological Macromolecules;2019-07

5. Insights of synthetic analogues of anti-leprosy agents;Bioorganic & Medicinal Chemistry;2019-07